These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33420084)

  • 21. L-Fucose production by engineered Escherichia coli.
    Liu JJ; Lee JW; Yun EJ; Jung SM; Seo JH; Jin YS
    Biotechnol Bioeng; 2019 Apr; 116(4):904-911. PubMed ID: 30597526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial fermentation platform for producing artificial aromatic amines.
    Masuo S; Zhou S; Kaneko T; Takaya N
    Sci Rep; 2016 May; 6():25764. PubMed ID: 27167511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escherichia coli coculture for de novo production of esters derived of methyl-branched alcohols and multi-methyl branched fatty acids.
    Bracalente F; Sabatini M; Arabolaza A; Gramajo H
    Microb Cell Fact; 2022 Jan; 21(1):10. PubMed ID: 35033081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic engineering of Escherichia coli for the production of benzoic acid from glucose.
    Luo ZW; Lee SY
    Metab Eng; 2020 Nov; 62():298-311. PubMed ID: 33068735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Artificial Biosynthetic Pathway for 2-Amino-1,3-Propanediol Production Using Metabolically Engineered Escherichia coli.
    Luo Y; Zhao Q; Liu Q; Feng Y
    ACS Synth Biol; 2019 Mar; 8(3):548-556. PubMed ID: 30781944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of Dynamic Regulation to Increase L-Phenylalanine Production in
    Wu J; Liu Y; Zhao S; Sun J; Jin Z; Zhang D
    J Microbiol Biotechnol; 2019 Jun; 29(6):923-932. PubMed ID: 31154747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering Metabolic Pathways for Cofactor Self-Sufficiency and Serotonin Production in
    Shen P; Gu S; Jin D; Su Y; Wu H; Li Q; Yang J; He W; Huang J; Qi F
    ACS Synth Biol; 2022 Aug; 11(8):2889-2900. PubMed ID: 35866382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing Agmatine Production in
    Xu D; Zhang L
    J Agric Food Chem; 2019 Jul; 67(28):7908-7915. PubMed ID: 31268314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic engineering of Corynebacterium glutamicum for enhanced production of 5-aminovaleric acid.
    Shin JH; Park SH; Oh YH; Choi JW; Lee MH; Cho JS; Jeong KJ; Joo JC; Yu J; Park SJ; Lee SY
    Microb Cell Fact; 2016 Oct; 15(1):174. PubMed ID: 27717386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.
    Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P
    Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing biosynthetic pathway for the production of p-hydroxyacetophenone and its glucoside in Escherichia coli.
    Lu L; Wang X; Zhou L; Liu Q; Zhang G; Xue B; Hu C; Shen X; Sun X; Yan Y; Wang J; Yuan Q
    Metab Eng; 2023 Mar; 76():110-119. PubMed ID: 36746296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated strain engineering and bioprocessing strategies for high-level bio-based production of 3-hydroxyvalerate in Escherichia coli.
    Miscevic D; Mao JY; Kefale T; Abedi D; Huang CC; Moo-Young M; Chou CP
    Appl Microbiol Biotechnol; 2020 Jun; 104(12):5259-5272. PubMed ID: 32291486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of Carminic Acid by Metabolically Engineered
    Yang D; Jang WD; Lee SY
    J Am Chem Soc; 2021 Apr; 143(14):5364-5377. PubMed ID: 33797895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manipulation of the precursor supply for high-level production of longifolene by metabolically engineered Escherichia coli.
    Cao Y; Zhang R; Liu W; Zhao G; Niu W; Guo J; Xian M; Liu H
    Sci Rep; 2019 Jan; 9(1):95. PubMed ID: 30643175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPRi/dCpf1-mediated dynamic metabolic switch to enhance butenoic acid production in Escherichia coli.
    Ji X; Zhao H; Zhu H; Zhu K; Tang SY; Lou C
    Appl Microbiol Biotechnol; 2020 Jun; 104(12):5385-5393. PubMed ID: 32338294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering a novel biosynthetic pathway in Escherichia coli for production of renewable ethylene glycol.
    Pereira B; Zhang H; De Mey M; Lim CG; Li ZJ; Stephanopoulos G
    Biotechnol Bioeng; 2016 Feb; 113(2):376-83. PubMed ID: 26221864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering and manipulation of a mevalonate pathway in Escherichia coli for isoprene production.
    Liu CL; Bi HR; Bai Z; Fan LH; Tan TW
    Appl Microbiol Biotechnol; 2019 Jan; 103(1):239-250. PubMed ID: 30374674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of DR1558, a Deinococcus radiodurans response regulator, on the production of GABA in the recombinant Escherichia coli under low pH conditions.
    Park SH; Sohn YJ; Park SJ; Choi JI
    Microb Cell Fact; 2020 Mar; 19(1):64. PubMed ID: 32156293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-level production of 3-hydroxypropionic acid from glycerol as a sole carbon source using metabolically engineered Escherichia coli.
    Kim JW; Ko YS; Chae TU; Lee SY
    Biotechnol Bioeng; 2020 Jul; 117(7):2139-2152. PubMed ID: 32227471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of pure meso-2,3-butanediol from crude glycerol using an engineered metabolic pathway in Escherichia coli.
    Lee S; Kim B; Park K; Um Y; Lee J
    Appl Biochem Biotechnol; 2012 Apr; 166(7):1801-13. PubMed ID: 22434350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.